Independence Day wasn't the only thing Abbott (Abbott Park, Illinois) celebrated over the holiday weekend last month. FDA approval of the company's Xience stent was reason enough to shoot off fireworks. Abbott received approval of Xience V everolimus-eluting coronary stent for the treatment of coronary artery disease on July 2, making it the second of the 2.0 family of drug-eluting stents to win marketing approval in the U.S. (Cardiovascular Devices & Drugs)